Evaluate the Value of Telehomecare for Diabetes

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 221 participants.

Also called NCT02813343

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose supportive care
Phase
Not applicable
Enrolled
  • 221 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02813343
Other papers using this trial's data
  • Mobile App for Improved Self-Management of Type 2 Diabetes: Multicenter Pragmatic Randomized Controlled Trial JMIR mHealth and uHealth, 2019-01-10 DOI, PubMed 30632972, PMC6329896 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02813343. Randomized; single masking; primary purpose supportive care. Start 2016-04 (actual); primary completion 2017-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluate the Value of Telehomecare for Diabetes
Intervention (Device)
BlueStar app
Lead sponsor
Women's College Hospital (class: other)
Collaborator
North York General Hospital (class: other)
Collaborator
William Osler Health System (class: other)
Collaborator
St. Joseph's Care Group (class: other)
Collaborator
Ontario Telemedicine Network (OTN) (class: not stated)
Collaborator
Unity Health Toronto (class: other)

Record details

Record id
cardio:ct-nct02813343
Content hash
ca2345389db49af263a7d1d1a660357c84b3a9a5f78615d1fa5b039aa5664eb4